ZOETIS INC. (ZTS)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.70 (+0.91%)Past Day

About

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Key Insights

  • Share Price

    $188.35

  • Market Cap

    $85.33 Billion

  • Total Outstanding Shares

    453.05 Million Shares

  • Total Employees

    14,100

  • Dividend

    $0.432 Per Share Quarterly

  • IPO Date

    February 1, 2013

  • SIC Description

    Pharmaceutical Preparations

  • Homepage

    https://www.zoetis.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow From Investing Activities$-744.00 Million
Exchange Gains/Losses$-17.00 Million
Net Cash Flow From Operating Activities, Continuing$2.72 Billion
Net Cash Flow From Operating Activities$2.72 Billion
Net Cash Flow, Continuing$-126.00 Million
Net Cash Flow From Financing Activities$-2.10 Billion
Net Cash Flow From Financing Activities, Continuing$-2.10 Billion
Net Cash Flow From Investing Activities, Continuing$-744.00 Million
Net Cash Flow$-143.00 Million

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Selling, General, and Administrative Expenses$2.22 Billion
Basic Average Shares$1.37 Billion
Net Income/Loss Available To Common Stockholders, Basic$2.34 Billion
Other Operating Expenses$1.13 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Gross Profit$6.24 Billion
Income/Loss From Continuing Operations Before Tax$2.89 Billion
Income/Loss From Continuing Operations After Tax$2.34 Billion
Income Tax Expense/Benefit, Deferred$-179.00 Million
Benefits Costs and Expenses$6.02 Billion
Net Income/Loss$2.34 Billion
Net Income/Loss Attributable To Noncontrolling Interest$-2.00 Million
Costs And Expenses$6.02 Billion
Revenues$8.91 Billion
Operating Expenses$3.34 Billion
Diluted Earnings Per Share$5.11
Basic Earnings Per Share$5.11
Cost Of Revenue$2.68 Billion
Interest Expense, Operating$235.00 Million
Net Income/Loss Attributable To Parent$2.34 Billion
Diluted Average Shares$1.38 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Nonoperating Income/Loss$-15.00 Million
Income Tax Expense/Benefit$552.00 Million
Operating Income/Loss$2.89 Billion

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Current Assets$6.20 Billion
Assets$14.16 Billion
Equity$4.96 Billion
Accounts Payable$420.00 Million
Intangible Assets$1.23 Billion
Inventory$2.45 Billion
Liabilities And Equity$14.16 Billion
Equity Attributable To Parent$4.97 Billion
Wages$276.00 Million
Other Current Liabilities$1.10 Billion
Other Current Assets$3.75 Billion
Liabilities$9.21 Billion
Equity Attributable To Noncontrolling Interest$-6.00 Million
Noncurrent Assets$7.96 Billion
Current Liabilities$1.80 Billion
Fixed Assets$3.20 Billion
Other Non-current Assets$3.54 Billion
Noncurrent Liabilities$7.41 Billion

Historical Dividends

Current dividend: $0.432 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 10, 2024Dec 3, 2024Oct 31, 2024$0.432Quarterly
May 22, 2024Sep 4, 2024Jul 18, 2024$0.432Quarterly
Feb 6, 2024Jun 4, 2024Apr 19, 2024$0.432Quarterly
Dec 7, 2023Mar 1, 2024Jan 19, 2024$0.432Quarterly
Oct 12, 2023Dec 1, 2023Nov 1, 2023$0.375Quarterly
May 11, 2023Sep 1, 2023Jul 21, 2023$0.375Quarterly
Feb 8, 2023Jun 1, 2023Apr 21, 2023$0.375Quarterly
Dec 8, 2022Mar 1, 2023Jan 20, 2023$0.375Quarterly
Oct 13, 2022Dec 1, 2022Nov 1, 2022$0.325Quarterly
May 19, 2022Sep 1, 2022Jul 21, 2022$0.325Quarterly
Feb 8, 2022Jun 1, 2022Apr 21, 2022$0.325Quarterly
Dec 7, 2021Mar 1, 2022Jan 20, 2022$0.325Quarterly
Oct 14, 2021Dec 1, 2021Oct 29, 2021$0.25Quarterly
May 20, 2021Sep 1, 2021Jul 21, 2021$0.25Quarterly
Feb 10, 2021Jun 1, 2021Apr 21, 2021$0.25Quarterly
Dec 9, 2020Mar 1, 2021Jan 20, 2021$0.25Quarterly
Oct 7, 2020Dec 1, 2020Oct 21, 2020$0.2Quarterly
May 20, 2020Sep 1, 2020Jul 17, 2020$0.2Quarterly
Feb 11, 2020Jun 1, 2020Apr 17, 2020$0.2Quarterly
Dec 11, 2019Mar 3, 2020Jan 17, 2020$0.2Quarterly
Oct 3, 2019Dec 2, 2019Oct 22, 2019$0.164Quarterly
May 15, 2019Sep 3, 2019Jul 19, 2019$0.164Quarterly
Feb 12, 2019Jun 3, 2019Apr 18, 2019$0.164Quarterly
Dec 12, 2018Mar 1, 2019Jan 18, 2019$0.164Quarterly
Oct 10, 2018Dec 3, 2018Nov 20, 2018$0.126Quarterly
May 15, 2018Sep 4, 2018Jul 20, 2018$0.126Quarterly
Feb 13, 2018Jun 1, 2018Apr 20, 2018$0.126Quarterly
Dec 11, 2017Mar 1, 2018Jan 19, 2018$0.126Quarterly
Oct 5, 2017Dec 1, 2017Nov 9, 2017$0.105Quarterly
May 11, 2017Sep 1, 2017Jun 15, 2017$0.105Quarterly
Feb 14, 2017Jun 1, 2017Apr 6, 2017$0.105Quarterly
Dec 6, 2016Mar 1, 2017Jan 20, 2017$0.105Quarterly
Oct 6, 2016Dec 1, 2016Nov 3, 2016$0.095Quarterly
Feb 19, 2016Jun 1, 2016Apr 7, 2016$0.095Quarterly
Jul 21, 2015Sep 1, 2015Aug 13, 2015$0.083Quarterly
Feb 27, 2015Jun 2, 2015Apr 9, 2015$0.083Quarterly
Dec 17, 2014Mar 3, 2015Jan 22, 2015$0.083Quarterly
Oct 2, 2014Dec 2, 2014Nov 5, 2014$0.072Quarterly
Jul 31, 2014Sep 2, 2014Aug 20, 2014$0.072Quarterly
Mar 26, 2014Jun 2, 2014Apr 28, 2014$0.072Quarterly
Dec 19, 2013Mar 4, 2014Jan 30, 2014$0.072Quarterly
Sep 12, 2013Dec 2, 2013Nov 1, 2013$0.065Quarterly
Jun 20, 2013Sep 2, 2013Aug 1, 2013$0.07Quarterly
Mar 28, 2013Jun 6, 2013May 1, 2013$0.065Quarterly
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
News ArticlesAbout UsPrivacy Policy & Cookies Information

ⓒ2024 Financhle. All Rights Reserved.